Execution Stability
The operational nerve center. Strategies to eliminate batch failures, close deviation loops, and build a manufacturing floor that performs consistently under pressure.
Most Teams Skip the Most Important Question
May 20, 2026 • By Paul Van Buskirk
Most organizations do not struggle to identify problems. They struggle to interpret them. In pharmaceutical manufacturing, teams are surrounded by dashboards, metrics, deviations, CAPAs, and operational data—yet the same execution issues continue to persist. This Field Guide explores the difference between “The What,” “The So What,” and “The Now What,” and why operational recovery depends on more than visibility alone. Because identifying the problem is only the beginning. Translating it into disciplined execution is where leadership actually begins.
Quality System Governance Archetypes: The Faucet, the Sink, and the Drain
May 12, 2026 • By Mike Barlow, Paul Van Buskirk
Many GMP governance meetings are overloaded with metrics but starved for operational clarity. Today's GMPKit Field Guide article introduces a simple stock-to-flow model—the faucet, sink, and drain—to help pharmaceutical operations and quality leaders identify hidden backlog formation, predict system saturation earlier, and transform Quality System KPI review from administrative reporting into operational control.
Can You Write the Ship?
April 21, 2026 • By Paul Van Buskirk
AI can generate answers that look right—but what happens when teams lose the ability to build them on their own? In GxP environments, this isn’t just a technology risk—it’s a capability risk that shows up in execution, decision-making, and ultimately, Cost of Poor Quality.
Dashboards Don’t Stop Debris
February 26, 2026 • By Paul Van Buskirk
Dashboards were never meant to be decorative. The original dashboard existed to stop debris before it reached the passenger. Modern business dashboards do the opposite — they measure the mess after it hits. In pharmaceutical manufacturing, that mess shows up as lost batches, deviation backlog, delayed disposition, and rework — the true drivers of Cost of Poor Quality. Visibility alone does not prevent failure. Structural correction does.